Here's exactly what you'll receive upon submitting your inquiry. Designed specifically for healthcare professionals.
🔬
Scientific Platform Document
Full OPC biochemistry, mechanism of action, and microvascular science — 24 pages with citations.
🏥
14 Specialty Clinical Briefs
One-page summaries for each specialty: relevance, rationale, patient profiles, and positioning.
📊
Selected Literature References
Curated bibliography of 40+ peer-reviewed studies on OPC and microvascular health.
💊
Product Technical Sheet
Full product specifications, regulatory status, storage, contraindications, and prescribing guidance.
Complete the form below to receive your dossier:
✅
Dossier Request Received
Our medical affairs team will email your clinical dossier within 24 business hours.
We use essential cookies and anonymised analytics to improve your experience. By continuing, you agree to our Privacy Policy (DPDPA compliant). No advertising cookies are used.
Advanced Microvascular Antioxidant
Tauphyx
95% OPC · Grape Seed Extract
India's most precisely standardised microvascular antioxidant — supporting endothelial health across 14 medical specialties. Manufactured by GoIntegrity Healthcare.
0%OPC Purity
0Specialties
0mgPer Capsule
0+Studies
95% OPC Purity
GoIntegrity Healthcare
₹2,979 MRP
✓FSSAI Compliant
🏥Recommended by Doctors
🔬95% OPC Standardised
💊30-Day Supply
🧠14 Specialties
🏭GoIntegrity Healthcare
Purity Matters
Why 95% OPC Changes Everything
Most grape seed extracts contain 40–60% OPC. Tauphyx delivers 95% — the highest commercially available, ensuring maximum antioxidant activity at every dose.
Tauphyx
95% OPC
Standard Extract
40–55% OPC
Generic GSE
15–18% OPC
Parameter
Tauphyx
Standard OPC
Generic GSE
OPC Standardisation
95%
40–55%
15–20%
Botanical Source
Vitis vinifera (Grape Seed)
Varied
Unspecified
Dose per Capsule
125 mg
100–150 mg
Varies
Hard Gelatin Capsule
✔
Sometimes
✗
FSSAI Compliant
✔
Varies
Varies
Specialist Clinical Support
✔ 14 Specialties
Limited
✗
Clinical Dossier Available
✔
✗
✗
🫀
Microvascular Integrity
OPCs are studied for cross-linking collagen fibres in capillary walls — strengthening microvascular networks and resisting oxidative degradation.
🔴
Endothelial Support
May support nitric oxide bioavailability via eNOS activation, promoting healthy endothelial function and modulating inflammatory signalling.
🍇
Vitis vinifera Science
Derived from the most rigorously studied OPC botanical source — with over 1,000 peer-reviewed studies on its antioxidant and vascular properties.
Doctor Voices
Recommended by Specialists
Healthcare professionals across specialties share their perspective on Tauphyx as an adjunctive microvascular nutraceutical.
★★★★★
The 95% OPC standardisation is what sets this apart. My patients with cerebrovascular risk factors now have a credible antioxidant option I can recommend with confidence.
Dr. R.K. Sharma
Consultant Neurologist · Delhi
★★★★★
In my diabetic patients with early microangiopathy, I've added Tauphyx as part of a comprehensive antioxidant strategy. The clinical rationale is sound and well-supported by literature.
Dr. M. Iyer
Endocrinologist · Chennai
★★★★★
For patients with poor endometrial perfusion, I wanted a high-purity OPC option. Tauphyx is exactly what was missing — the clinical dossier made the recommendation easy to justify.
Dr. P. Mehta
IVF Specialist & Gynaecologist · Mumbai
Testimonials represent individual clinical opinions. Results may vary. Not substitute for evidence-based treatment.
Clinical Applications
One Platform, 14 Specialties
Search by specialty or organ system to find the clinical rationale most relevant to your practice.
🔍
The Product
Precision in Every Capsule
Active Ingredient
Grape Seed Extract (Vitis vinifera)
Standardisation
95% OPC
Strength
125 mg per capsule
Dosage Form
Hard Gelatin Capsule
Pack Size
30 Capsules
MRP
₹2,979
Manufacturer
GoIntegrity Healthcare Pvt Ltd
Regulatory
Nutraceutical Supplement (FSSAI)
How to Use
Take 1 capsule daily, preferably with meals or as directed by your healthcare professional. Store below 25°C away from moisture and light. Not recommended during pregnancy without medical supervision.
Maximum Retail Price
₹2,979
30 Capsules · 1-Month Supply
For Healthcare Professionals
HCP Inquiry & Clinical Dossier
Request the full Tauphyx clinical dossier, specialty literature, or product samples for your practice.
✅
Thank you, Doctor.
Your inquiry has been received. Our medical affairs team will respond within 24 business hours.
India's most precisely standardised 95% OPC microvascular antioxidant, by GoIntegrity Healthcare.
Brand Identity
Tauphyx is a premium nutraceutical brand by GoIntegrity Healthcare Pvt Ltd, India. Built around a single, scientifically compelling active — 95% OPC Grape Seed Extract (Vitis vinifera) at 125 mg per capsule — standardised to the highest purity commercially available.
GoIntegrity Healthcare
Committed to science-backed nutraceutical solutions for India's healthcare professionals and patients. GMP-compliant manufacturing, FSSAI registered, with medical affairs support across 14 clinical specialties.
Our Mission
To bring the highest-quality, evidence-informed nutraceuticals to Indian healthcare — designed for specialist recommendation and trusted by patients. Tauphyx targets HCPs first across 14 disciplines who recognise microvascular health as a common upstream denominator.
Market Position
Primary: India. International expansion planned. ₹2,979 MRP · 30-capsule one-month supply · Premium physician-recommended category · Highest-purity OPC in the Indian nutraceutical market.
Understanding the biochemical mechanisms by which high-purity oligomeric proanthocyanidins may support microvascular health.
What Are Oligomeric Proanthocyanidins (OPCs)?
OPCs are polyphenolic flavonoids naturally found in grape seeds. They are polymers of flavan-3-ol monomers (catechin and epicatechin), and their biological activity derives from polyhydroxylated ring structures. The "oligomeric" fraction — chains of 2–10 units — is considered most biologically active, offering optimal molecular weight for intestinal absorption while retaining potent antioxidant capacity.
Antioxidant Mechanisms
Direct scavenging of reactive oxygen species (ROS) and reactive nitrogen species
Chelation of transition metal ions involved in Fenton chemistry
Inhibition of pro-oxidant enzymes (xanthine oxidase, NADPH oxidase)
Upregulation of endogenous antioxidant enzymes (SOD, catalase, GPx)
Vascular Mechanisms
eNOS activation and nitric oxide bioavailability support
Inhibition of NF-κB — central transcription factor in vascular inflammation
Collagen cross-linking stabilisation in capillary walls
MMP (matrix metalloproteinase) inhibition for matrix integrity
Why 95% Standardisation Matters
Most commercial grape seed extracts are standardised to 40–60% OPC, or sometimes to total polyphenols rather than the oligomeric fraction. Tauphyx at 95% OPC ensures virtually the entire active content of each 125 mg capsule consists of biologically active oligomeric fraction — enabling reproducible dosing and alignment with research populations.
Complete technical, regulatory, and clinical information for Tauphyx.
Specifications
Brand Name
Tauphyx
Active Ingredient
Grape Seed Extract (Vitis vinifera)
Standardisation
95% Oligomeric Proanthocyanidins (OPC)
Strength
125 mg per capsule
Dosage Form
Hard Gelatin Capsule
Pack Size
30 Capsules (1-month supply)
MRP
₹2,979 (inclusive of all taxes)
Route
Oral
Storage
Below 25°C — protect from moisture and light
Manufacturer
GoIntegrity Healthcare Pvt Ltd
Regulatory Category
Nutraceutical Food Supplement (FSSAI)
How to Use
1 capsule daily with meals, or as directed by your healthcare professional. Do not exceed recommended dose. Consult physician if on anticoagulant therapy.
MRP
₹2,979
30 Capsules · 1 Month
Structure/Function Claims
Microvascular integrity and endothelial function support
Oxidative stress management
Cardiovascular and cerebrovascular antioxidant defence
Blood pressure support within normal range
Cognitive support through cerebral microcirculation
Cerebral microcirculation, blood-brain barrier integrity, and small vessel disease — the neurological case for 95% OPC.
Microvascular Relevance
The brain is among the most metabolically demanding organs, dependent entirely on intact microvascular perfusion. Cerebral small vessel disease (SVD), white matter changes, and lacunar infarcts reflect microvascular dysfunction. OPC's endothelial-supportive properties make it potentially relevant to cerebrovascular health maintenance.
Scientific Rationale
OPCs may cross the blood-brain barrier (small MW forms)
Antioxidant protection of cerebral endothelium against ROS
NF-κB modulation may reduce neuroinflammatory signalling
NO support for cerebral autoregulation
MMP inhibition may stabilise BBB integrity
Clinical Context
Neurologists managing patients with cerebrovascular risk, white matter changes, or cognitive complaints may find Tauphyx a relevant adjunctive nutraceutical. Not a replacement for neurological therapies.
SEO: Tauphyx for Neurology | Cerebral Microvascular Antioxidant
Neuroinflammation, cerebral blood flow, and the emerging vascular hypothesis of mood disorders.
Microvascular Relevance
Psychiatric research increasingly recognises neuroinflammation and cerebral microvascular dysfunction as relevant factors in depression, anxiety, and some psychotic disorders. Reduced cerebral blood flow and endothelial dysfunction have been documented in several psychiatric conditions.
Scientific Rationale
Cerebral blood flow via NO-eNOS pathway support
Neuroinflammation modulation through NF-κB inhibition
Oxidative stress reduction in neuronal microenvironments
Psychiatrists considering adjunctive nutraceuticals may consider Tauphyx for patients with comorbid vascular profiles. Not a substitute for psychiatric medication. Review potential interactions.
CMD, HFpEF, endothelial dysfunction — the cardiovascular case for 95% OPC.
Microvascular Relevance
Coronary microvascular dysfunction (CMD) is increasingly recognised as a distinct clinical entity, particularly in HFpEF and angina without obstructive CAD. Endothelial dysfunction and oxidative stress are central mechanisms, making antioxidant support a logical adjunct.
Scientific Rationale
Endothelial NO support — may improve coronary microvascular tone
Antioxidant protection against LDL oxidation
Anti-inflammatory via NF-κB pathway
Capillary wall strengthening through collagen cross-linking
Blood pressure support in normal physiological range
Clinical Context
Cardiologists managing CMD, hypertension, metabolic syndrome, or early atherosclerosis may consider Tauphyx as adjunct. Does not replace statins, antihypertensives, or other evidence-based therapies.
Pelvic microvascular health, vasculogenic dysfunction, and urinary tract antioxidant support.
Microvascular Relevance
Penile erection and urinary continence both depend on intact pelvic microvasculature. Vasculogenic erectile dysfunction is fundamentally an endothelial disease. OPC's NO-support and antioxidant properties are directly relevant here.
Scientific Rationale
NO-eNOS support may improve cavernosal smooth muscle relaxation
Antioxidant protection of urinary tract epithelium
Anti-inflammatory relevant to prostatitis and UTI
Microvascular integrity of pelvic organs
Clinical Context
Urologists may consider Tauphyx for vasculogenic ED, overactive bladder, recurrent UTI antioxidant support, and BPH adjunct management. Not a PDE5 inhibitor or antibiotic.
Ischaemia-reperfusion injury and peri-operative microvascular support.
Microvascular Relevance
Spinal cord and neural tissue are exquisitely sensitive to ischaemia. Surgical retraction and positioning can compromise local microvascular perfusion. Ischaemia-reperfusion injury generates massive oxidative stress — antioxidant support during the peri-operative window may have protective value.
Scientific Rationale
Potent ROS scavenging — particularly in reperfusion
MMP inhibition for neurological matrix
BBB-relevant protection for intracranial procedures
Collagen cross-linking for wound healing
Clinical Context
Considered as peri-operative antioxidant adjunct for spinal fusion, disc surgery, cranial procedures. Always coordinate with anaesthesia and pharmacy teams.
Pulmonary microvascular health and Long COVID vascular sequelae.
Microvascular Relevance
The pulmonary vasculature faces direct contact with inhaled oxidants and inflammatory mediators. PAH, Long COVID, and COPD all involve significant pulmonary microvascular remodelling and endothelial dysfunction.
Scientific Rationale
Antioxidant defence against inhaled ROS and mediators
Endothelial protection for pulmonary vascular tone
Potential role in Long COVID vascular sequelae — investigational
Anti-inflammatory for COPD oxidative burden
Clinical Context
PAH adjunct (alongside standard therapy), Long COVID vascular symptoms, COPD. Not a bronchodilator or pulmonary vasodilator.
Splanchnic microcirculation, IBD mucosal protection, and hepatic oxidative stress in NAFLD.
Microvascular Relevance
The GI tract has one of the richest microvascular networks in the body. Mucosal perfusion is critical for epithelial integrity, and disruption underlies conditions from IBD to NAFLD. The hepatic sinusoidal network is a key target in liver disease.
Scientific Rationale
Hepatic antioxidant effects studied in NAFLD models
Anti-inflammatory modulation of gut mucosal immune response
Endometrial perfusion, implantation failure, and reproductive microvascular optimisation.
Microvascular Relevance
Successful endometrial implantation requires adequate sub-endometrial blood flow. Poor uterine perfusion is a recognised factor in implantation failure and recurrent pregnancy loss. Ovarian microcirculation influences follicular development and oocyte quality.
Scientific Rationale
NO-eNOS support may improve uterine blood flow
Antioxidant protection of oocytes and endometrial cells
Collagen support for endometrial matrix
PCOS — antioxidant and inflammatory context
Clinical Context
Poor endometrial perfusion, recurrent implantation failure, thin endometrium, PCOS-related oxidative burden. Contraindicated in confirmed pregnancy without specialist review.
Use in oncology patients is strictly in supportive/palliative care under the supervising oncologist. Antioxidant supplementation during active chemotherapy or radiotherapy may interfere with treatment. Investigational only — full oncology team coordination required.
Diabetic microangiopathy, AGE inhibition, metabolic syndrome — the endocrine case for 95% OPC.
Microvascular Relevance
Diabetic microangiopathy — affecting retinal, renal, and peripheral microvasculature — is among the most common causes of microvascular disease globally. Oxidative stress and glycation are central mechanisms, making OPC's antioxidant and anti-glycation properties highly relevant.
Scientific Rationale
AGE inhibition studied in OPC extracts
Antioxidant defence against diabetes-induced ROS
Endothelial support in insulin-resistant states
PCOS — antioxidant context
Aldose reductase inhibition — polyol pathway
Clinical Context
T2DM adjunct, metabolic syndrome, early diabetic nephropathy, PCOS. Does not replace insulin, metformin, or other diabetic therapies.
Endothelial senescence, inflammaging, frailty, and polypharmacy considerations.
Microvascular Relevance
Ageing is associated with progressive endothelial senescence, reduced NO bioavailability, increased microvascular stiffness, and a pro-inflammatory vascular phenotype. These changes contribute to frailty, cognitive decline, and multi-organ functional loss.
Scientific Rationale
Anti-senescence antioxidant mechanisms
eNOS support counteracts age-related NO decline
Anti-inflammatory signalling — inflammaging
Collagen cross-link stabilisation for vessel ageing
Clinical Context
Review polypharmacy carefully — anticoagulant interactions. Consider as part of holistic healthy ageing strategy for cognitively and cardiovascularly at-risk elderly patients.
Cerebral palsy, HIE, and perinatal stroke — paediatric neuroprotective context.
⚠️ Paediatric Use Notice
Use in children must be under supervision of a qualified paediatric neurologist only. Off-label. Requires informed parental consent.
Potential Neuroprotective Context
Cerebral palsy — oxidative stress and microvascular component
HIE — antioxidant support post-event
Perinatal stroke — post-acute antioxidant support
Childhood migraine with vascular component
Clinical Context
Work within paediatric specialist networks. Review available case literature. Use minimum effective doses under strict monitoring. Parent communication and consent essential.
ASD, developmental delay, and mitochondrial dysfunction.
⚠️ Developmental Paediatrics Notice
Must be directed by a qualified developmental paediatrician. Multidisciplinary team framework required. Parental consent and communication essential.
Research Context
ASD — oxidative stress and mitochondrial dysfunction
Global developmental delay — microvascular and metabolic factors
Rett syndrome — oxidative stress component, investigational
Clinical Context
Clear parental communication about nutraceutical (not drug) status. Regular review of therapeutic goals and safety monitoring within the MDT framework.
Full legal, FSSAI, and CDSCO compliance notice for Tauphyx.
Nutraceutical Status
Tauphyx is a nutraceutical food supplement, not a drug or medicine. Manufactured and marketed in compliance with FSSAI regulations governing food supplements in India. Not a scheduled drug under the Drugs and Cosmetics Act, 1940, and not regulated by CDSCO as a pharmaceutical product.
Claims Notice
All claims associated with Tauphyx are structure/function claims only. These claims have not been evaluated by FDA, CDSCO, or any drug regulatory authority as claims for prevention, treatment, mitigation, or cure of any disease or medical condition.
"Recommended by Doctors"
Where this phrase appears, it refers to individual healthcare professionals who have independently reviewed and recommended this product. Not a formal endorsement by any medical association, hospital, or regulatory body. Not a prescription under pharmaceutical law.
Anticoagulant / Antiplatelet Warning
Grape seed extract (OPC) may have mild antiplatelet properties. Patients on warfarin, heparin, aspirin, clopidogrel, or other anticoagulant or antiplatelet therapies should consult their physician before use.
A curated overview of peer-reviewed research underpinning the Tauphyx scientific platform.
About the Evidence Base
Grape Seed Extract (Vitis vinifera) and its OPCs have been the subject of over 1,000 peer-reviewed studies. The following categories represent key areas of scientific literature relevant to Tauphyx's clinical positioning. Not all studies used the exact standardisation in Tauphyx. Individual results may vary.
Cardiovascular Research
Multiple RCTs report statistically significant reductions in systolic blood pressure following grape seed extract supplementation. OPC supplementation has been associated with reduced oxidised LDL levels in several clinical studies.
Neurological Research
Animal and in vitro studies suggest OPCs can cross the blood-brain barrier and exert neuroprotective antioxidant effects. NF-κB pathway inhibition by OPCs documented in multiple cell-based studies.
Metabolic & Endocrine Research
Studies in diabetic models show OPC may inhibit advanced glycation end-products (AGEs) and aldose reductase, both relevant to diabetic microangiopathy progression.
Reproductive & IVF Research
NO-mediated uterine blood flow has been a subject of research in implantation success. Antioxidant supplementation is a recognised strategy in IVF support protocols globally.
Request Full Literature Dossier
Healthcare professionals may request the complete Tauphyx clinical literature dossier — 40+ curated references — from our medical affairs team.
How GoIntegrity Healthcare Pvt Ltd collects, uses, and protects your data.
Data Collection
Personal data submitted through the HCP Inquiry form is used solely for responding to your inquiry and internal medical affairs communications. Fields collected: name, specialty, institution, city, email.
Data Use & DPDPA Compliance
GoIntegrity Healthcare Pvt Ltd is committed to compliance with the Digital Personal Data Protection Act, 2023 (DPDPA), India. Data subjects have the right to access, correct, and request erasure of personal data. Contact: info@tauphyx.com
No sale or transfer to third parties for marketing
